Inhibidores de azaquinazoline de proteína atípica kinase c
COMPUESTOS DERIVADOS DE pirido[3,4-d]pirimidina; COMPOSICION FARMACEUTICA QUE LOS COMPRENDE Y EL USO PARA TRATAR UN TRASTORNO O CONDICION DEPENDIENTE DE APKC TAL COMO UN TRASTORNO PROLIFERATIVO. The present application provides azaquinazoline compounds as defined herein. This application further des...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GREGORY R. OTT ALLISON L. ZULLI KATHERINE M. FOWLER EUGEN F. MESAROS CRAIG A. ZIFICSAK IKEOLUWA OLOWAYE ROBERT L. HUDKINS NATHANIEL JT MONCK CHRISTELLE N. SOUDY HENRY J. BRESLIN BRUCE D. DORSEY JONATHAN R.A. ROFFEY MING TAO EMMA L. MORRIS BENJAMIN J. DUGAN GREGOIRE A PAVE |
| description | COMPUESTOS DERIVADOS DE pirido[3,4-d]pirimidina; COMPOSICION FARMACEUTICA QUE LOS COMPRENDE Y EL USO PARA TRATAR UN TRASTORNO O CONDICION DEPENDIENTE DE APKC TAL COMO UN TRASTORNO PROLIFERATIVO.
The present application provides azaquinazoline compounds as defined herein. This application further describes compositions comprising the same. These azaquinazoline compounds and their salts have atypical protein kinase C ("aPKC") inhibitory activity, and may be used to treat proliferative disorders. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CL2015000781A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CL2015000781A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CL2015000781A13</originalsourceid><addsrcrecordid>eNrjZLDxzMvITMpMyS9KLVZISVVIrEosLM3MS6zKz8nMSwWJFBTll6QeXpuXqJBYcnhtQWZyokI2UEFxqkIyDwNrWmJOcSovlOZmUHZzDXH20E0tyI9PLS5ITE7NSy2Jd_YxMjA0NTAwMLcwdDQ0Jk4VADlOMcs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Inhibidores de azaquinazoline de proteína atípica kinase c</title><source>esp@cenet</source><creator>GREGORY R. OTT ; ALLISON L. ZULLI ; KATHERINE M. FOWLER ; EUGEN F. MESAROS ; CRAIG A. ZIFICSAK ; IKEOLUWA OLOWAYE ; ROBERT L. HUDKINS ; NATHANIEL JT MONCK ; CHRISTELLE N. SOUDY ; HENRY J. BRESLIN ; BRUCE D. DORSEY ; JONATHAN R.A. ROFFEY ; MING TAO ; EMMA L. MORRIS ; BENJAMIN J. DUGAN ; GREGOIRE A PAVE</creator><creatorcontrib>GREGORY R. OTT ; ALLISON L. ZULLI ; KATHERINE M. FOWLER ; EUGEN F. MESAROS ; CRAIG A. ZIFICSAK ; IKEOLUWA OLOWAYE ; ROBERT L. HUDKINS ; NATHANIEL JT MONCK ; CHRISTELLE N. SOUDY ; HENRY J. BRESLIN ; BRUCE D. DORSEY ; JONATHAN R.A. ROFFEY ; MING TAO ; EMMA L. MORRIS ; BENJAMIN J. DUGAN ; GREGOIRE A PAVE</creatorcontrib><description>COMPUESTOS DERIVADOS DE pirido[3,4-d]pirimidina; COMPOSICION FARMACEUTICA QUE LOS COMPRENDE Y EL USO PARA TRATAR UN TRASTORNO O CONDICION DEPENDIENTE DE APKC TAL COMO UN TRASTORNO PROLIFERATIVO.
The present application provides azaquinazoline compounds as defined herein. This application further describes compositions comprising the same. These azaquinazoline compounds and their salts have atypical protein kinase C ("aPKC") inhibitory activity, and may be used to treat proliferative disorders.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160401&DB=EPODOC&CC=CL&NR=2015000781A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160401&DB=EPODOC&CC=CL&NR=2015000781A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GREGORY R. OTT</creatorcontrib><creatorcontrib>ALLISON L. ZULLI</creatorcontrib><creatorcontrib>KATHERINE M. FOWLER</creatorcontrib><creatorcontrib>EUGEN F. MESAROS</creatorcontrib><creatorcontrib>CRAIG A. ZIFICSAK</creatorcontrib><creatorcontrib>IKEOLUWA OLOWAYE</creatorcontrib><creatorcontrib>ROBERT L. HUDKINS</creatorcontrib><creatorcontrib>NATHANIEL JT MONCK</creatorcontrib><creatorcontrib>CHRISTELLE N. SOUDY</creatorcontrib><creatorcontrib>HENRY J. BRESLIN</creatorcontrib><creatorcontrib>BRUCE D. DORSEY</creatorcontrib><creatorcontrib>JONATHAN R.A. ROFFEY</creatorcontrib><creatorcontrib>MING TAO</creatorcontrib><creatorcontrib>EMMA L. MORRIS</creatorcontrib><creatorcontrib>BENJAMIN J. DUGAN</creatorcontrib><creatorcontrib>GREGOIRE A PAVE</creatorcontrib><title>Inhibidores de azaquinazoline de proteína atípica kinase c</title><description>COMPUESTOS DERIVADOS DE pirido[3,4-d]pirimidina; COMPOSICION FARMACEUTICA QUE LOS COMPRENDE Y EL USO PARA TRATAR UN TRASTORNO O CONDICION DEPENDIENTE DE APKC TAL COMO UN TRASTORNO PROLIFERATIVO.
The present application provides azaquinazoline compounds as defined herein. This application further describes compositions comprising the same. These azaquinazoline compounds and their salts have atypical protein kinase C ("aPKC") inhibitory activity, and may be used to treat proliferative disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDxzMvITMpMyS9KLVZISVVIrEosLM3MS6zKz8nMSwWJFBTll6QeXpuXqJBYcnhtQWZyokI2UEFxqkIyDwNrWmJOcSovlOZmUHZzDXH20E0tyI9PLS5ITE7NSy2Jd_YxMjA0NTAwMLcwdDQ0Jk4VADlOMcs</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>GREGORY R. OTT</creator><creator>ALLISON L. ZULLI</creator><creator>KATHERINE M. FOWLER</creator><creator>EUGEN F. MESAROS</creator><creator>CRAIG A. ZIFICSAK</creator><creator>IKEOLUWA OLOWAYE</creator><creator>ROBERT L. HUDKINS</creator><creator>NATHANIEL JT MONCK</creator><creator>CHRISTELLE N. SOUDY</creator><creator>HENRY J. BRESLIN</creator><creator>BRUCE D. DORSEY</creator><creator>JONATHAN R.A. ROFFEY</creator><creator>MING TAO</creator><creator>EMMA L. MORRIS</creator><creator>BENJAMIN J. DUGAN</creator><creator>GREGOIRE A PAVE</creator><scope>EVB</scope></search><sort><creationdate>20160401</creationdate><title>Inhibidores de azaquinazoline de proteína atípica kinase c</title><author>GREGORY R. OTT ; ALLISON L. ZULLI ; KATHERINE M. FOWLER ; EUGEN F. MESAROS ; CRAIG A. ZIFICSAK ; IKEOLUWA OLOWAYE ; ROBERT L. HUDKINS ; NATHANIEL JT MONCK ; CHRISTELLE N. SOUDY ; HENRY J. BRESLIN ; BRUCE D. DORSEY ; JONATHAN R.A. ROFFEY ; MING TAO ; EMMA L. MORRIS ; BENJAMIN J. DUGAN ; GREGOIRE A PAVE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CL2015000781A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GREGORY R. OTT</creatorcontrib><creatorcontrib>ALLISON L. ZULLI</creatorcontrib><creatorcontrib>KATHERINE M. FOWLER</creatorcontrib><creatorcontrib>EUGEN F. MESAROS</creatorcontrib><creatorcontrib>CRAIG A. ZIFICSAK</creatorcontrib><creatorcontrib>IKEOLUWA OLOWAYE</creatorcontrib><creatorcontrib>ROBERT L. HUDKINS</creatorcontrib><creatorcontrib>NATHANIEL JT MONCK</creatorcontrib><creatorcontrib>CHRISTELLE N. SOUDY</creatorcontrib><creatorcontrib>HENRY J. BRESLIN</creatorcontrib><creatorcontrib>BRUCE D. DORSEY</creatorcontrib><creatorcontrib>JONATHAN R.A. ROFFEY</creatorcontrib><creatorcontrib>MING TAO</creatorcontrib><creatorcontrib>EMMA L. MORRIS</creatorcontrib><creatorcontrib>BENJAMIN J. DUGAN</creatorcontrib><creatorcontrib>GREGOIRE A PAVE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GREGORY R. OTT</au><au>ALLISON L. ZULLI</au><au>KATHERINE M. FOWLER</au><au>EUGEN F. MESAROS</au><au>CRAIG A. ZIFICSAK</au><au>IKEOLUWA OLOWAYE</au><au>ROBERT L. HUDKINS</au><au>NATHANIEL JT MONCK</au><au>CHRISTELLE N. SOUDY</au><au>HENRY J. BRESLIN</au><au>BRUCE D. DORSEY</au><au>JONATHAN R.A. ROFFEY</au><au>MING TAO</au><au>EMMA L. MORRIS</au><au>BENJAMIN J. DUGAN</au><au>GREGOIRE A PAVE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Inhibidores de azaquinazoline de proteína atípica kinase c</title><date>2016-04-01</date><risdate>2016</risdate><abstract>COMPUESTOS DERIVADOS DE pirido[3,4-d]pirimidina; COMPOSICION FARMACEUTICA QUE LOS COMPRENDE Y EL USO PARA TRATAR UN TRASTORNO O CONDICION DEPENDIENTE DE APKC TAL COMO UN TRASTORNO PROLIFERATIVO.
The present application provides azaquinazoline compounds as defined herein. This application further describes compositions comprising the same. These azaquinazoline compounds and their salts have atypical protein kinase C ("aPKC") inhibitory activity, and may be used to treat proliferative disorders.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_CL2015000781A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Inhibidores de azaquinazoline de proteína atípica kinase c |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A06%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GREGORY%20R.%20OTT&rft.date=2016-04-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECL2015000781A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |